Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial

Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T16:30:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide notice announces changes to NIH websites and a transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T19:24:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:36:10.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T22:40:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a basic header and footer. It shows no study details or locations, indicating the page is currently inaccessible.
    Difference
    23%
    Check dated 2026-09-20T22:34:49.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page's revision marker was bumped from v3.6.5 to v3.6.6, indicating a maintenance/metadata update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-30T22:30:35.000Z thumbnail image

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.